Asia
The Asian market for Amoxicillin demonstrated significant volatility during the second half of 2024. The market initially experienced price declines due to sluggish demand and weak consumption levels in both domestic and international markets. China, in particular, faced challenges with limited support from downstream sectors and rising freight costs due to maritime disruptions.
However, the trend shifted upward in the later months as industries adapted to the Red Sea conflict challenges and demand from end-user industries strengthened. The market also faced additional pressure from port congestions and logistical hurdles, which contributed to supply tightness.
Europe
European Amoxicillin prices showed a mixed trend throughout the latter half of 2024. The market initially saw downward pressure due to weaker demand in key markets like Germany, particularly in the pharmaceutical sector. However, prices began to rise as companies implemented strategic inventory management in response to potential supply disruptions. The ongoing Red Sea conflict created logistical challenges that constrained supply, while improved consumer sentiment helped revitalize demand. Market participants actively built stockpiles in anticipation of shipping delays, which further supported the price increase.
North America
North American Amoxicillin prices followed a dynamic pattern in H2’24. The market began with a downward trend as inflation rates stabilized, leading to reduced overhead costs for businesses. However, this trend reversed in the later months as consumer confidence reached new highs, driven by an improved economic outlook. The market saw increased buying activity as participants began building inventories in anticipation of rising demand and potential supply chain challenges. The combination of strengthening demand and logistical concerns helped sustain the upward price momentum.
Analyst Insight
According to Procurement Resource, the Amoxicillin market is expected to maintain its bullish trend into 2025, primarily driven by ongoing supply chain challenges, potential production constraints, and steady demand from the pharmaceutical sector.
Related Report

Turn price intelligence into action with the Procurement Resource Database. Log in or subscribe to unlock live price trends, historical charts, supplier databases, cost curves, and analyst-backed insights across chemicals, agriculture, energy, packaging, and more. Use these tools to benchmark your contracts, plan budgets with confidence, and stay ahead of market moves on every product you buy.

0
+Products
0
+Regions
0
+Subscriptions
Asia
The initial phase of the first half of 2024 gave a strong start to the Amoxicillin market. Although after this phase, the price trend of Amoxicillin in Asia displayed fluctuations driven by multiple factors.
The market initially experienced stable prices due to sufficient inventories and a balanced supply-demand scenario. However, toward the end of this period, the trend shifted upward due to increased external demand and production constraints in major factories. Additional upward pressure came from supply chain disruptions, congestion in key Asian ports, and logistical challenges affecting exports. These factors collectively contributed to a price increase for Amoxicillin in the region.
Europe
In Europe, Amoxicillin prices saw a gradual upward trend throughout the first half of 2024. Early in the year, prices remained relatively steady as the market adapted to changing supply chain dynamics and geopolitical tensions that affected shipping routes. The demand for Amoxicillin from downstream industries, coupled with logistical hurdles and higher shipping costs, led to an increase in prices. This trend was even sustained even in the later stages of the second quarter unlike the Asian countries, supported by the positive demand from both domestic and international markets, particularly from North America, supporting the continued upward movement in Amoxicillin prices.
North America
In North America, the Amoxicillin market experienced a positive price trend during the first half of 2024. Strong domestic demand from the healthcare sector, alongside supply constraints, provided upward momentum for prices. The region also faced logistical challenges due to disruptions like the collapse of the Key Bridge in Baltimore and the impact of global geopolitical tensions. These supply chain issues, combined with increased export interest from Europe, further bolstered the price increases for Amoxicillin in North America throughout this period.
Asia
A gradual fall in the prices of amoxicillin was observed in both the third and fourth quarters of 2023. During both quarters, the fall was majorly influenced by the muted demand from the downstream industries in both domestic and overseas markets. In this depreciation of prices, the reduction in the cost of crude oil also played a significant role. The consequence of this was the decline in the cost of feedstock material and the overall cost of production of amoxicillin and, in turn, its prices. However, during the last month of the year, there was a slight spike in the market's momentum with a minimal positive change in prices.
Europe
The shift in consumer interests and appreciation in the rates of interest hindered the movement of amoxicillin prices during both the third and fourth quarters of 2023. In addition to these major challenges, the industrial as well as consumer spending budgets were reduced by a great margin under inflationary pressure. On the other hand, the supply of amoxicillin remained smooth in the European countries, only to pile up as inventories, further prompting the traders to reduce their profit margins and the quoted prices of amoxicillin.
North America
Similar to the European countries, the North American market of amoxicillin also curbed under the pressure of inflation throughout the third and fourth quarters of 2023. The major negative influence on the market activities was exerted by the reshaping dynamics of the downstream pharmaceutical and healthcare industries. In addition to this, to support the dropping economic indicators, the banking sector increased its interest rates, which led to limited borrowing activities and decreased investments in the amoxicillin sector.
Asia
The amoxicillin market in the first and second quarters of 2023 showcased an upward trajectory in the first quarter of 2023. The influence of strong recovery of the market after the Lunar holidays affected the Asia market positively as the number of new orders increased from domestic and international buyers. However, the second quarter was not favorable for the amoxicillin prices. The trend dipped significantly in this quarter. The major cause of this decline is attributed to the slowing of production processes and weak market sentiments that caused a negative impact on the demand from healthcare, pharmaceuticals, and related industries.
Europe
In Europe, the prices of amoxicillin declined in the first quarter and second quarters of 2023. The disbalance in the supply-demand equilibria is caused by the weak purchasing potential of buyers. Another factor that played a significant role in deciding the trend of amoxicillin was the excessive supply from both domestic and international buyers due to the relief in the trading protocols, especially by Germany. Along with this, the slowing down of the economy, also due to hikes in interest rates along with rising influence, eventually led to the downfall in the prices of amoxicillin.
North America
The amoxicillin price trend declined in both the first and second quarters of 2023. In the first quarter, the prices declined slowly as compared to the second quarter. The trend suffered from the decrease in the number of orders from the domestic and overseas markets while the supply in the region remained strong. In addition to this, the influx of imports from China at lower prices affected the amoxicillin market negatively. In addition to this, the rising inflation slowed down the market activities, and as a result, traders were forced to sell the produce at lower rates.
Asia
The Amoxicillin market in Asia had a good run in H2 2022. Demands from the pharma industry and end consumers remained steady throughout the second half of the year 2022. Seasonal and situational fluctuations occurred, but overall, the price trend for Amoxicillin kept steady. Good demand from the pharma sector and continuous supply kept the market running. Hot weather affected production for some time rising the prices, but as the weather improved supplies too became rampant.
Europe
The Amoxicillin market in Europe remained demand dependent in H2 2022. During Q3 2022, the supplies were limited attributing to very strict Chinese restrictions and curtailed freight arrangements. The European market is very import dependent for most pharma products, so as supplies stumbled, prices hiked. Because of all these reasons, Amoxicillin price trend remained up-inclined during the majority of 2022. It was only in the later Q4 that market demands subsided a little bit controlling the prices. Overall amoxicillin prices plateaued after a long, good run.
North America
The North American market replicated the price trend observed in the European market. As both markets are very dependent on Chinese imports, the effects of the Chinese manufacturing slowdown were deeply felt across the global markets. North American market too registered steady demands, but supply cutbacks drove the price trend. The price trend remained high for most of H2 2022, only in later December, market demands subsided lowering the Amoxicillin prices a little bit.
North America
Due to growing demand from the downstream pharmaceutical industry and other logistical challenges, amoxicillin prices rose in the second quarter of 2022. The supply chain in local and international markets was interrupted by the implementation of lockdowns and tight rules in exporting nations. The 10% price increase that took effect at the beginning of the quarter also had an impact on the cost of amoxicillin. The prices also rose dramatically as a result of the soaring demand and rising operating costs.
Europe
The market price of amoxicillin was stable at the end of the second quarter of 2022 due to stable demand, which lowered its price. Amoxicillin prices remained stable due to adequate supply and existing inventories. Furthermore, strong demand for the drug by various healthcare sectors at the end of March prompted domestic merchants to lower their prices. For the first two months, the market was hampered by consistent operating costs and production rates. Amoxicillin prices increased slightly toward the end of Q2 2022, reaching 10500 USD/MT, with a 90% q-o-q decline.
Asia
Amoxicillin prices increased in the second quarter of 2022 due to increased demand from the downstream healthcare industry. The imposition of a lockdown in China's financial capital Shanghai disrupted the supply chain in regional and international markets. In the latter half of the quarter, the government-imposed policies stating a 10% price increase, which affected amoxicillin prices. Furthermore, the pandemic initially created a high demand for analgesics such as amoxicillin, which led to increased demand and higher operating costs, causing prices to skyrocket.
Amoxicillin is a narrow-spectrum penicillin antibiotic. It treats bacterial infections, such as chest infections, skin infections, urinary tract infections, and dental abscesses. It is taken by mouth or, less commonly, by injection. Amoxicillin belongs to the beta-lactam class of antibiotics, and it was discovered by scientists at Beecham Research Laboratories in 1972. It is the most prescribed medication for children and should not be given to individuals allergic to penicillin.
C16H19N3O5S
Antibiotics, Pharmaceutical, Skin infections, Chest infections
Amoxycillin, Amox
Sinopharm Weiqida, Teva API, Otto Brandes GmbH, United Pharma Industries Co Ltd, Indukern Chemie AG
CurrencyUS$ (Data can also be provided in local currency)
Supplier Database AvailabilityYes
Customization ScopeThe report can be customized as per the requirements of the customer
Post-Sale Analyst Support360-degree analyst support after report delivery
Note: Our supplier search experts can assist your procurement teams in compiling and validating a list of suppliers indicating they have products, services, and capabilities that meet your company's needs.
Penicillin G acylase enzyme immobilized on glyoxyl-agarose is used to catalyze the reaction between p -hydroxyphenylglycine methyl ester (POHPGME) and 6-aminopenicillanic acid (6-APA) to obtain Amoxicillin.
Our Price Analysis Methodology

Experience how Procurement Resource transforms raw material price data into clear, decision ready intelligence. Optimise your performance with reliable, expert market data and analysis. Schedule your demo today to experience a live walk-through where our experts will showcase interactive price charts, forecasted prices, and insights driving the prices for your key commodities, tailored to your workflows. Contact us now!
Our Team will be happy to assist you
We are just a text away
Still Need Help ?
Unlock full access to Procurement Resource's price databases, interactive charts, and short-term forecasts for thousands of commodities. Elevate your sourcing decisions by comparing prices across regions, downloading historical data, and layering in analyst-backed insights, all with our flexible plans that scale as your portfolio grows.
Still have any Questions
Contact Us



Price Trend Dashboard - What's Included
Price trends across a diverse portfolio of categories amd products, spanning board to niche chemicas
Coverage extendable to grade-specific chemicals based on procurement requirements
Regular price tracking supported by robust historical datasets
News, policy updates, and key market drivers impacting price movements
Short-term and long-term price outlooks and forecasts
Supply–demand dynamics and capacity-driven market analysis